OnKure Therapeutics, Inc. (OKUR) Misses Q4 EPS by 130c

OnKure Therapeutics, Inc. (NASDAQ: OKUR) reported Q4 EPS of ($1.37), $1.30 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on OnKure Therapeutics, Inc. (OKUR) click here.

You May Also Be Interested In

• PVH Corp. (PVH) Tops Q2 EPS by 62c, Beats on Revenue; Offers FY27 EPS Guidance
• Phreesia Inc. (PHR) Misses Q2 EPS by 6c; Offers Guidance
• Chargepoint Holdings Inc. (CHPT) Tops Q2 EPS by 25c, Beats on Revenue